Trending...
- Santa Monica Businesses Push Back on Bus Stop Relocation That Threatens Access and Safety
- Medicare Levy Exemption 2025: Nanak Accountants Releases Step-by-Step Tax Guide for Australians
- GreenPal Empowers Lawn Care Pros Leveraging AI, Surpasses 5 Million Transactions
Addition of Large Format, HP Multi Jet Fusion 580 Additive Manufacturing Platform Enhances Capabilities.
MURRIETA, Calif. - AussieJournal -- REV•1 Engineering, a leading developer of complex, interventional medical technologies, is introducing next generation 3D printer technology in support of their early phase, medical device development capabilities. The company is known for it's ground-breaking work in interventional cardiology, structural heart, neuromodulation and drug/device/biologics combination technologies.
"The addition of the HP 580 printer is a game changer for early-phase design and development", commented Eric Johnson, Co-Founder and CEO of REV•1. "The technology is already delivering commercial orthotics and prosthetics. Its impact on cutting costs and accelerating early development timelines for more complex medical devices will be significant."
More on Aussie Journal
The speed and flexibility of this new technology enables clients to produce multiple, three dimensional design iterations, simultaneously, in a single production batch. What was once done sequentially can now be done in parallel.
"Being able to evaluate multiple prototype options in a single afternoon delivers a significant advantage," added Mr. Johnson. "The quality and affordability of the materials used by the HP 580 printer also speed development and deliver real cost savings. We envision this cutting currently hand fabricated prototype costs by two thirds, a significant issue as these hand made devices can cost thousands of dollars to fabricate."
Earlier generations of 3D printers produced parts that lacked the strength and durability necessary for meaningful, early bench and pre-clinical testing. Until now, this required the use of "soft tooling"; temporary tools used for injection molding cut from cheap steel to save money. These tools are frequently sourced from China. Soft steel tools degrade quickly, limiting the number of quality parts that can be produced to support Verification & Validation testing and additional pre-clinical and clinical studies. The 580 printer produces identical, high quality components every time.
More on Aussie Journal
"The critical factor here is time," said Terry Murray, Vice President of Strategic Development with REV•1. "Soft tooling takes time to source, design, cut, ship and install on presses for the initial injection molding runs to produce parts. All of that dead time falls away, saving weeks, if not months, in the development process."
"Companies are also looking into the biocompatibility of the materials the 580 can run," said Mr. Johnson. "Once biocompatibility can be validated, this will open up entirely new manufacturing pathways for implants and interventional technologies. We're truly standing on the threshold of an exciting future for medical technology."
"The addition of the HP 580 printer is a game changer for early-phase design and development", commented Eric Johnson, Co-Founder and CEO of REV•1. "The technology is already delivering commercial orthotics and prosthetics. Its impact on cutting costs and accelerating early development timelines for more complex medical devices will be significant."
More on Aussie Journal
- Hazara Leaders Give Voice to Human Rights Awareness
- Trust funds: are they still worth the effort?
- SeedList Launching Institutional Crypto Crowdfunding Project to Empower Retail Investors and Disrupt the VC-Dominated Crypto Fundraising Landscape
- California Family Launches Billboard to Reach "Pardon Czar" Alice Marie Johnson
- Rent Like A Champion Acquires CollegeWeekends
The speed and flexibility of this new technology enables clients to produce multiple, three dimensional design iterations, simultaneously, in a single production batch. What was once done sequentially can now be done in parallel.
"Being able to evaluate multiple prototype options in a single afternoon delivers a significant advantage," added Mr. Johnson. "The quality and affordability of the materials used by the HP 580 printer also speed development and deliver real cost savings. We envision this cutting currently hand fabricated prototype costs by two thirds, a significant issue as these hand made devices can cost thousands of dollars to fabricate."
Earlier generations of 3D printers produced parts that lacked the strength and durability necessary for meaningful, early bench and pre-clinical testing. Until now, this required the use of "soft tooling"; temporary tools used for injection molding cut from cheap steel to save money. These tools are frequently sourced from China. Soft steel tools degrade quickly, limiting the number of quality parts that can be produced to support Verification & Validation testing and additional pre-clinical and clinical studies. The 580 printer produces identical, high quality components every time.
More on Aussie Journal
- Sumter Landing Dental Care Launches Summer Special on Full Mouth Reconstruction
- Seligson Law Launches New Website to Support Cannabis Businesses in California and New York
- databahn Announces Subscription Access to Fortune 500 GenAI Deep Dive Sales Intelligence Reports
- AI startup Congero offers instant websites with 24/7 updates - aiming to replace web agencies
- WonderDays Launches the UK's First AI Experience Gift Finder – Gifting Just Got So Much Easier!
"The critical factor here is time," said Terry Murray, Vice President of Strategic Development with REV•1. "Soft tooling takes time to source, design, cut, ship and install on presses for the initial injection molding runs to produce parts. All of that dead time falls away, saving weeks, if not months, in the development process."
"Companies are also looking into the biocompatibility of the materials the 580 can run," said Mr. Johnson. "Once biocompatibility can be validated, this will open up entirely new manufacturing pathways for implants and interventional technologies. We're truly standing on the threshold of an exciting future for medical technology."
Source: REV.1 Engineering
Filed Under: Business
0 Comments
Latest on Aussie Journal
- Why Elephants Cry and Pigs Sing: New Children's Book Reveals the Deep Emotional World of Animals in Stunning Verse
- SmartSwaps Launches Personalised Food Swap Plans to Take the Guesswork Out of Healthy Eating
- The Modern Insurance Store Expands Medicare Help Services for Seniors in Cincinnati
- Ironside HR Named Fastest-Growing Staffing Firm for Second Year
- Inframark Continues to Build Its Community Management Capabilities and Multi-Disciplinary Presence in Arizona
- ICAST 2025: The Crystal-Clear Revolution Begins at Booth #3233
- Brindle Pet Supplies Now Carries Badlands Ranch Dog Food in Canada
- $10 Million Allocated to Establish Crypto Treasury Focused on High Value Ethereum (ETH) & Bitcoin (BTC) as Long-Term Holdings for Cybersecurity Leader
- Sing For Your Supper: A Night of Musical Comedy and Drag for a Great Cause
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- $100 to $200 Million Equity Agreement with Top Digital Advisor Bitwise to Power Major Digital Asset Initiative for Bitcoin and Solana: OFA Group
- New Collaboration Launches Corporate ESG Solution for Responsible Decommissioning and Transparent Reporting
- SlickCashLoan Launches Free Loan Calculator to Help You Plan Monthly Payments
- World Landscape Architecture Unveils Highly Anticipated 2025 WLA Awards Shortlist
- TikTok Star ArcadeFriends Attempts 24-Hour Claw Machine Marathon at Lucky Puppy Arcade in Las Vegas
- Pyro Marketing Launches New Website to Accelerate Growth for Fitness Brands
- KCON LA 2025, 106.3 RAIN FM 'Take Over' Special Event
- The Citizens Commission on Human Rights Annual Purple Heart Day Event will be Hosted at the Historic Fort Harrison
- Blake Harris the Leading Authority in International Asset Protection Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- Psychedelics for Vets? CCHR Cites History of Exploitation and Failed Science